Our work is supported by:

DZIF
German Center for Infection Research



German Center for Infection Research (DZIF)

We are funded through the German Center for Infection Research (DZIF) for the development of a SARS Corona vaccine ( link ) and as part of the Working Group "Clinical management and epidemiology of emerging infections" ( link ).

Marylyn Addo is the spokesperson and coordinator of the DZIF Research Area 'Emerging infections' (TTU EI).

DZIF is one of the six German Centers for Health Research ( DZG ) Deutsche Zentren der Gesundheitsforschung (DZG)


Contact Melanie Richter, Project Manager Emerging Infections

DFG
German Research Foundation

German Research Foundation

German Research Foundation / DFG

We are part of the DFG-funded Research Unit for studying sex differences in immunity.

Increasing evidence suggests that common biological pathways regulating immune cell function are involved in sex-specific differences in immunity to self (autoimmune diseases and malignancies) or to foreign (pathogens, vaccines).

Find out more on sex differences in immunity:
Research Unit 5068 | Sex differences in immunity

Contact Tamara Zoran, Scientist

BMBF
Federal Ministry for Education and Research


Federal Ministry of Education and Research

BMBF

The BMBF funds a single center study of the immunogenicity of recombinant Vesicular Stomatitis vaccine for Ebola-Zaire (rVSV∆G-ZEBOV-GP) for pre-exposure prophylaxis in individuals at potential occupational risk for Ebola virus exposure – EU Site Germany (PREPARE-Germany).

Contact Anahita Fathi, Clinician Scientist

CEPI
CEPI

CEPI

CEPI

CEPI finances the two-center, randomized, double-blind, placebo-controlled, phase Ib study to assess the safety, tolerability and immunogenicity of two ascending doses of the candidate vaccine MVA-MERS-S_DF-1 in healthy study subjects.

Contact Svenja Hardtke, Coordinator

Netzwerk Universitätsmedizin
Netzwerk Universitätsmedizin



netzwerk universitäts medizin

NUM

Research network of university medical centers

NAPKON
NAPKON


Nationales Pandemie Kohorten Netz

NAPKON

Further cooperation partners:

  • Ludwig-Maximilians-Universität München LMU
  • IDT Biologika Link
  • Philipps Universität Marburg Link
  • Erasmus Medical Center Rotterdam Link
  • Universitätsklinikum Köln Link
  • Eberhard Karls Universität Tübingen Link
  • Helmholz Munich Link
  • Technical University of Munich Link